ASND – Ascendis Pharma A/S
ASND — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
6.33
Margin Of Safety %
-21
Put/Call OI Ratio
0.13
EPS Next Q Diff
1.6
EPS Last/This Y
8.99
EPS This/Next Y
6.58
Price
217.16
Target Price
284.05
Analyst Recom
1.22
Performance Q
1.95
Upside
-167.8%
Beta
0.5
Ticker: ASND
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-02-27 | ASND | 233.52 | 0.28 | 0.12 | 14388 |
| 2026-03-02 | ASND | 242.34 | 0.27 | 0.17 | 14784 |
| 2026-03-03 | ASND | 240.22 | 0.26 | 0.39 | 14663 |
| 2026-03-04 | ASND | 241.71 | 0.26 | 0.18 | 14820 |
| 2026-03-05 | ASND | 237.58 | 0.27 | 0.48 | 14861 |
| 2026-03-06 | ASND | 241 | 0.25 | 0.17 | 15062 |
| 2026-03-09 | ASND | 240.1 | 0.24 | 0.05 | 16525 |
| 2026-03-10 | ASND | 240.54 | 0.23 | 0.01 | 17274 |
| 2026-03-11 | ASND | 227.29 | 0.23 | 0.14 | 17458 |
| 2026-03-12 | ASND | 229.01 | 0.18 | 0.21 | 20522 |
| 2026-03-13 | ASND | 229.01 | 0.18 | 0.21 | 20522 |
| 2026-03-17 | ASND | 228.29 | 0.17 | 0.03 | 20922 |
| 2026-03-18 | ASND | 227.53 | 0.17 | 0.76 | 20966 |
| 2026-03-19 | ASND | 223.64 | 0.17 | 1.42 | 20988 |
| 2026-03-20 | ASND | 221.94 | 0.17 | 0.15 | 20966 |
| 2026-03-23 | ASND | 218.07 | 0.14 | 0.05 | 16455 |
| 2026-03-24 | ASND | 215.6 | 0.14 | 0.03 | 16775 |
| 2026-03-25 | ASND | 220.9 | 0.13 | 0.69 | 17019 |
| 2026-03-26 | ASND | 220.43 | 0.14 | 0.17 | 17077 |
| 2026-03-27 | ASND | 216.97 | 0.13 | 0.23 | 17043 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | ASND | 233.51 | 131.7 | 390.3 | 4.65 |
| 2026-03-02 | ASND | 242.03 | 131.7 | 398.7 | 4.65 |
| 2026-03-03 | ASND | 239.06 | 131.7 | 395.8 | 4.65 |
| 2026-03-04 | ASND | 241.48 | 131.7 | 398.1 | 4.65 |
| 2026-03-05 | ASND | 237.34 | 131.3 | 394.1 | 4.53 |
| 2026-03-06 | ASND | 240.70 | 131.3 | 401.5 | 4.53 |
| 2026-03-09 | ASND | 239.96 | 129.6 | 396.1 | 4.52 |
| 2026-03-10 | ASND | 240.72 | 128.1 | 396.8 | 4.52 |
| 2026-03-11 | ASND | 227.54 | 128.1 | 383.9 | 4.52 |
| 2026-03-12 | ASND | 228.79 | 128.1 | 385.1 | 4.52 |
| 2026-03-13 | ASND | 226.03 | 128.1 | 382.4 | 4.52 |
| 2026-03-17 | ASND | 228.30 | 128.1 | 384.6 | 4.52 |
| 2026-03-18 | ASND | 227.50 | 128.2 | 383.8 | 4.56 |
| 2026-03-19 | ASND | 223.72 | 128.2 | 380.1 | 4.56 |
| 2026-03-20 | ASND | 221.88 | 128.2 | 378.3 | 4.56 |
| 2026-03-23 | ASND | 218.26 | 128.2 | 374.8 | 4.56 |
| 2026-03-24 | ASND | 215.68 | 128.2 | 372.2 | 4.56 |
| 2026-03-25 | ASND | 220.63 | 128.2 | 377.1 | 4.56 |
| 2026-03-26 | ASND | 220.61 | 128.2 | 377.1 | 4.56 |
| 2026-03-27 | ASND | 217.16 | 128.2 | 373.7 | 4.56 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | ASND | 0.00 | -1.39 | 6.25 |
| 2026-03-02 | ASND | 0.00 | 1.40 | 6.25 |
| 2026-03-03 | ASND | 0.00 | 1.40 | 6.25 |
| 2026-03-04 | ASND | 0.00 | 1.40 | 6.25 |
| 2026-03-05 | ASND | 0.00 | 1.40 | 6.25 |
| 2026-03-06 | ASND | 0.00 | 1.40 | 6.25 |
| 2026-03-09 | ASND | 0.00 | 1.41 | 6.25 |
| 2026-03-10 | ASND | 0.00 | 1.41 | 6.25 |
| 2026-03-11 | ASND | 0.00 | 1.41 | 6.36 |
| 2026-03-12 | ASND | 0.00 | 1.41 | 6.36 |
| 2026-03-13 | ASND | 0.00 | 1.41 | 6.36 |
| 2026-03-17 | ASND | 0.00 | 1.42 | 6.36 |
| 2026-03-18 | ASND | 0.00 | 1.42 | 6.36 |
| 2026-03-19 | ASND | 0.00 | 1.42 | 6.36 |
| 2026-03-20 | ASND | 0.00 | 1.42 | 6.36 |
| 2026-03-23 | ASND | 0.00 | 1.42 | 6.36 |
| 2026-03-24 | ASND | 0.00 | 1.42 | 6.36 |
| 2026-03-25 | ASND | 0.00 | 1.42 | 6.33 |
| 2026-03-26 | ASND | 0.00 | 1.42 | 6.33 |
| 2026-03-27 | ASND | 0.00 | 1.42 | 6.33 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.64
Avg. EPS Est. Current Quarter
0.45
Avg. EPS Est. Next Quarter
0.96
Insider Transactions
Institutional Transactions
1.42
Beta
0.5
Average Sales Estimate Current Quarter
282
Average Sales Estimate Next Quarter
327
Fair Value
171.54
Quality Score
36
Growth Score
54
Sentiment Score
67
Actual DrawDown %
12.7
Max Drawdown 5-Year %
-60.5
Target Price
284.05
P/E
Forward P/E
17.78
PEG
P/S
16.18
P/B
P/Free Cash Flow
258.82
EPS
-4.2
Average EPS Est. Cur. Y
4.56
EPS Next Y. (Est.)
11.13
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-30.85
Relative Volume
0.87
Return on Equity vs Sector %
112.7
Return on Equity vs Industry %
129
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.16
EBIT Estimation
373.7
◆
ASND
Healthcare
$216.95
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
40.3
Range 1M
17.7%
Sup Dist
1.9%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
212.5%
EPS NY
150.2%
52W%
76.2%
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+39.7% upside
Upside
+39.7%
Quality
36
MoS
-21%
Ascendis Pharma A/SSector: Healthcare
Industry: Biotechnology
Employees: 1189
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
ASND
Latest News
—
Caricamento notizie per ASND…
stock quote shares ASND – Ascendis Pharma A/S Stock Price stock today
news today ASND – Ascendis Pharma A/S stock forecast ,stock prediction 2023 2024 2025
marketwatch ASND – Ascendis Pharma A/S yahoo finance google finance
stock history ASND – Ascendis Pharma A/S invest stock market
stock prices ASND premarket after hours
ticker ASND fair value insiders trading